Free Trial
→ He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (From The Oxford Club) (Ad)tc pixel
OTCMKTS:NSTM

NovelStem International 8/6/2025 Earnings Report

NovelStem International logo
$0.02 0.00 (0.00%)
As of 09:30 AM Eastern
ProfileEarnings History

NovelStem International EPS Results

Actual EPS
$0.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NovelStem International Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NovelStem International Announcement Details

Quarter
Date
8/6/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NovelStem International Earnings Headlines

NovelStem International Delays Q1 2025 Report Filing
May 15, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/novelstem-international-delays-q1-2025-report-filing?utm_source=marketbeat.com&utm_medium=referral
Arbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and Merchandising
July 13, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/arbitration-confirms-novelstem-joint-ventures-200300058.html?.tsrc=rss
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
September 8 at 2:00 AM  |  The Oxford Club (Ad)
Glencore International
April 24, 2023  |  forbes.comhttps://www.forbes.com/companies/glencore-international/
NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-K
March 31, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/novelstem-focused-patented-genetic-platform-185400973.html?.tsrc=rss
NovelStem's Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two Therapies
December 14, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/novelstems-affiliate-newstem-announced-collaboration-130100694.html?.tsrc=rss
See More NovelStem International Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NovelStem International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NovelStem International and other key companies, straight to your email.

About NovelStem International

NovelStem International (OTCMKTS:NSTM), a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

View NovelStem International Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles